The rate of major hemorrhage among patients in the apixaban group was @ % per year compared with @ % per year in the warfarin group ( hazard ratio -LSB- HR -RSB- @ , @ % confidence interval -LSB- CI -RSB- : @ to @ ; p < @ ) .